Electromagnetic induction device for ophthalmological treatments and pathologies related to dysfunctions of the visual system
A portable electromagnetic induction device with an RLC circuit and LEDs addresses the limitations of existing ophthalmological devices by providing effective, low-energy treatment for visual system dysfunctions without heating or side effects, suitable for home use.
Patent Information
- Application Number
- PCT/IB2026/050542
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-08
- Filing Date
- 2026-01-21
- Publication Date
- 2026-11-12
AI Technical Summary
Existing ophthalmological devices for treating visual system dysfunctions are bulky, expensive, require grid connection, and need medical supervision, limiting their use for home treatments and bedridden patients, and they cause side effects at higher energies.
A portable electromagnetic induction device with an RLC circuit and LEDs emitting at specific wavelengths, generating a coherent electromagnetic field to stimulate biological effects at low energies, avoiding heating and side effects.
The device provides effective therapeutic treatment for visual system dysfunctions with reduced dimensions, low cost, and no supervision, using low-energy signals, ensuring safety and efficacy.
Smart Images

Figure IB2026050542_12112026_PF_FP_ABST
Abstract
Description
[0001] "ELECTROMAGNETIC INDUCTION DEVICE FOR OPHTHALMOLOGICAL TREATMENTS AND PATHOLOGIES RELATED TO DYSFUNCTIONS OF THE VISUAL SYSTEM"
[0002] Cross-Reference to Related Applications This Patent Application claims priority from Italian Patent Application No . 102025000010389 filed on May 8, 2025, the entire disclosure of which is incorporated herein by reference .
[0003] Technical Field
[0004] The invention relates to an electromagnetic induction device for ophthalmological treatments and for the treatment of pathologies related to dysfunctions of the visual system. The usefulness of the device derives from the interaction of lights with specific wavelength with an electromagnetic field characterized by a specific intensity and by a specific frequency generated by a particular RLC oscillator circuit .
[0005] State of the Art
[0006] In the medical field, non-ionizing electromagnetic radiations have long been used in the treatment of numerous diseases . In particular, some radiations are used in the form of coherent, collimated and high-fluence light (LASER) , to obtain coagulative and photoablative effects .
[0007] Recent clinical studies have highlighted the possibility of stimulating animal tissues, including humanones, by using light with a very low irradiated energy ( fluence) , to obtain particular biological effects (reparative / regenerative, antiphlogistic, analgesic effects ) .
[0008] It has therefore been demonstrated that it is possible to induce biological effects by using physical devices that directly or indirectly transmit low-energy electromagnetic fields to tissues . These electromagnetic inductions are characterized by four main adjustable parameters, such as the frequency (or wavelength) , the intensity (conveyed energy) , the waveform (e . g. sine wave) and the duration of the stimulation.
[0009] The biological effects can be obtained by means of electric currents at ultra-low voltage, multifrequency electromagnetic fields at low frequency and also by means of specific devices that induce a modulation of cellular function through the process of Photobiomodulation, i . e . the administration of light with wavelengths generally ranging from red-orange to near-infrared. The light sources include, in addition to the Low Level Laser, non-coherent light sources such as light-emitting diodes (LEDs) , whose mechanism of action is based on the interaction between light and tissue chromophores .
[0010] The biological effect that can be obtained by light stimulation occurs thanks to the presence of particularphotosensitive molecules (chromoacceptors) , which, when activated by light with a particular wavelength, trigger a cascade of chemical-physical events that result in changes in the steady state of the tissue . The most striking example is the activation of the visual purples of the cones of the retina by red-blue-green radiation, for the vision of colours .
[0011] In particular, in recent clinical studies it has been reported that for age-related macular degeneration (AMD) , stimulation with 630nm, 660nm red light and 810nm nearinfrared red light leads to the improvement of the pathological picture (reduction of the volume of the drusen) and functional picture (increase in contrast sensitivity, visual acuity and improvement of the average retinal sensitivity) .
[0012] To date, devices have been produced and marketed that use wavelengths ranging from near-infrared to orange (X 810 - 600 nm) , with irradiance of the order of a few tens of m Watt / cm2. These devices are extremely bulky, expensive and can only be used when connected to the power grid and, especially, only under the supervision of specialized personnel .
[0013] Therefore, there is a need for an electromagnetic induction device for the treatment of ophthalmologic conditions and of other systemic pathologies related todysfunctions of the visual system, whose technical characteristics are such as to guarantee reduced dimensions, low costs, independence from the power grid, use without the supervision of medical or paramedical personnel (thus allowing bedridden patients to benefit from home treatments) , use of signals with very low fluence and at different wavelengths, selected according to the disease to be treated.
[0014] Description of the Invention
[0015] The subj ect-matter of the invention is a device comprising a portable support structure applicable to the head of a user and at least one electromagnetic induction group fixed to said portable support structure; said electromagnetic induction group comprising (i) an RLC circuit powered by an alternating voltage generator and (ii) at least one LED emitting at a wavelength between 1064 nm and 400 nm and a power between 1 and 300 Lux; said device being characterised in that said RLC circuit produces an electromagnetic field with a value between 10 and 100 micro Tesla and having an oscillation frequency between IxlO14and 8xl014Hz and in that said at least one LED emits a beam of light that passes through said electromagnetic field.
[0016] The inventors of this present invention designed a therapeutic device that exploits the Faraday effect of the electromagnetic field on the light that flows through it .When the electromagnetic field is oscillating, the rotation of the polarization plane and, as a consequence, the spin of the photons of the transmitted light beam, take place alternately clockwise and counterclockwise . Furthermore, since the light is polarized, as it is subj ected to the effect of the electromagnetic field, all the photons going through it will have the same spin (coherent) . The therapeutic effect produced by the device derives from the fact that during the oscillation of the polarization there is, in the time unit, at least one moment when the photons will be "in phase" with the biological target . In this way, a biological effect can be obtained even at low energies, hence without causing a heating of the substrate with the resulting side effects .
[0017] The inventors found operating conditions, in terms of electromagnetic field and frequency, to ensure efficacy in therapeutic terms .
[0018] The high frequency of the electromagnetic field guarantees the repetition of the situation in which the photons are "in phase" with the biological target .
[0019] Meanwhile, the low intensity of the electromagnetic field and the low intensity of the light of the LEDs guarantee the absence of side effects .
[0020] Preferably, said portable support structure is shaped like glasses .Preferably, said RLC circuit is fixed to said glasses and delimits a space occupied by a transparent dielectric .
[0021] Preferably, said device comprises at least three RGB LEDs .
[0022] Preferably, the alternating voltage generator has an amplitude between 10 mV and 12 V.
[0023] Preferably, the alternating voltage generator is an antenna with a head in the shape of a segment of a sphere with a diameter between 5.0 and 5.8 mm.
[0024] The above-mentioned antenna, when connected to the oscillating circuit, generates a very weak electromagnetic field with a relative alternating-current electromotive force, thus configuring itself as an "in air" transformer . Moreover, this leads to the determination of the aforementioned effect of polarization of the electromagnetic field caused by the light that flows through the field circumscribed by the circuit (Faraday' s law) .
[0025] In other words, by connecting an RLC circuit to an antenna, it produces oscillations within the circuit as if it were connected to an alternating voltage generator .
[0026] The invention defined above allows light with extremely low irradiance to be effective for the purposes of therapeutic treatment . The light emission is generated by commercial RGB LEDs, whose radiant energy has been set to obtain an irradiance at the target of the order of 30 nW / cm2.According to the invention, the biological effect (according to the Law of the Minimum Stimulus) of light with such low irradiance can be obtained by conditioning an RLC oscillator circuit, which is capable of making coherent the electromagnetic information that passes through the weak field generated therein.
[0027] Preferably, said LED provides a pulsed light with a frequency less than or equal to 1, 000.00 Hz as amplitude modulation of the light stimulus .
[0028] The invention is based on the principle that the interactions between tissues and physical stimuli are linked to the specificity of the signal and to the equivalence between different modes of induction.
[0029] Based on the above, the device of the invention makes it possible to use a stimulation system at extremely low energies, for it is able to increase some intrinsic characteristics of the physical stimulus, such as for example the coherence of the spins of the photons, using an electromagnetic field induced by an oscillator circuit . In this way, a very weak (monochromatic, theoretically not collimated and not coherent) radiation can become as effective as a very low fluence laser or relatively higher fluence LEDs, which, however, would suffer from the disadvantage of increasing the temperature of the target tissues (Joule effect) with the risk of causing mutations inthe DNA (potential teratogenicity) .
[0030] Brief Description of the Drawing
[0031] For a better understanding of the invention, an embodiment is disclosed below for explanatory and nonlimiting purposes, with the aid of the accompanying figure, which is a perspective view from above of an embodiment of the device according to the invention.
[0032] Description of Embodiments
[0033] In the figure, number 1 indicates, as a whole, an embodiment of the device according to the invention.
[0034] The device 1 comprises a glasses frame 2 consisting of a front 3 and two temples 4, each of which is hinged to the front 3 by means of a respective elastic hinge .
[0035] In the front 3, two circles 5 are defined, each housing a respective transparent dielectric 6.
[0036] On an inner surface 6a ( facing, in use, the user' s eyes) of each of the transparent dielectrics 6, a respective electromagnetic induction group 7 is fixed.
[0037] Each of the two electromagnetic induction groups 7 comprises an RLC circuit 8, which consists of a copper filament with a diameter between 0.4 and 0.6 mm connected to a spherical cap antenna 9 with a radius of 5.4 mm. The filament of the RLC circuit 8 is not visible as it is covered by a protective cover 10. The diameter of the RLC circuit 8 is 3.3 cm .The RLC circuit 8 comprises a capacitor (also covered by the protective cover 10) , which consists of two sheets of copper, or another electrically conductive material, preferably spaced apart from each other by a distance between 0.2 and 0. 6 mm and each being 3.0 x 1.0 x 0.5 mm in size .
[0038] Each of the two electromagnetic induction groups 7 comprises three LEDs 11 fixed to the protective cover 10 and powered by a relative current generator, which is known and, therefore, not described.
[0039] The three LEDs 11 emit a light with a wavelength equal to 630 nm, 532 nm, 475 nm, respectively, and are connected to an electric power supply capable of providing a voltage of 3.0 V.
[0040] The RLC circuit 8 generates an electromagnetic field with an extremely low intensity equal to 50 micro Tesla, which is traversed by ambient light and by the light emitted by the LEDs 11. In this way, the RLC circuit 8 sets the photons that pass through it into a coherent spin, making the signal, albeit having a very low energy, bioavailable and effective .
[0041] In particular, the antenna 9 described above produces an effective oscillation of the electromagnetic field with a frequency of 5xl014Hz .
[0042] The device 1 described above ensures that the distance of the LEDs from the eyeball is not less than 1.25 cm andthat the LEDs themselves are not centred with respect to the pupillary axis, to avoid direct illumination of the eye and to enable defocused, non-collimated and evenly diffused irradiation .
[0043] Preferably, a settable on-off generator can be inserted to modulate the amplitude of the stimulation and deliver pulsed light at a frequency less than or equal to 1000 Hz . Examples of pulsed light frequency can be : 256; 288, 320, 344, 392, 432, 480 Hz .
[0044] Below is an experimental investigation aimed at verifying the effects of device 1 on culture cells .
[0045] The antioxidant effects of the device were evaluated considering the applications aimed at ocular diseases related to ageing. Most diseases related to ageing derive, in fact, from a decrease in the efficiency of most cellular defence systems towards oxidative stress, both local and systemic .
[0046] There are two main pathways for the generation of Reactive Oxygen Species (ROS) . The first one is linked to mitochondria, which are associated with the electronic transport chain and to cytochrome P450. The second one is linked to nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) , in particular to phagocytic immune cells and endothelial cells, which are consequently associated with the inflammatory response .Although the study of these substances focuses on the products of cellular damage, they have important cellular functions as regulators and signalling agents in multiple processes such as apoptosis, mitophagy, adhesion and cellular differentiation. However, when the production of ROS exceeds the limits of the detoxification system in a prolonged or chronic way, these substances are considered the main mediators of the inflammatory pathology. Oxidative stress and inflammation share close pathophysiological processes, appearing simultaneously in many diseases and suggesting a relationship between both phenomena .
[0047] In order to evaluate the antioxidant effect, cell lines were used, which were subj ected to an oxidative stress was induced by means of H2O2 (500 pM) .
[0048] Cell lines
[0049] • SH-SY5Y human neuroblastoma cell line
[0050] • JURKAT -human T lymphocyte cell line
[0051] • ARPE-19 - human retinal pigment epithelial cell line .
[0052] The cells were cultured and maintained in RPMI-1640 supplemented with 10% fetal calf serum, L-glutamine (4 mM) , penicillin ( 100 U mL-1 ) and streptomycin ( 100 U mL-1 ) . Exponentially growing cells were treated at a density of 2xl06cells / ml . In the control treatment without oxidative stress, water was added to the samples instead of H2O2 . Afterthe incubation period, cellular responses to oxidative stress were assessed by free radical generation, cell viability and western blot analysis .
[0053] Toxicity assay
[0054] The Methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay (Sigma-Aldrich, St . Louis, MO, USA) was used to evaluate the metabolic activity of the cells exposed to the LEDs . The cells were seeded in duplicate 5xl05in 100 pL of complete medium in a 96-well plate . Briefly, the cells were kept in fresh serum-free medium for four hours to synchronize their growth. Subsequently, the medium was replaced with fresh serum-free medium and the cells were incubated for 24 and 48 hours with the device . The MTT reagent was added to each well, with a concentration of 0.5 mg / mL . After incubation at 37 °C for 2 hours, the yellowish solution was converted into intracellular crystals of dark blue MTT formazan insoluble in water, by the mitochondrial dehydrogenases of the living cells . The MTT / medium was removed and replaced with an equal volume of DMSO (Sigma-Aldrich, St . Louis, MO, USA) to solubilize the formazan cells and intracellular crystals . The absorbance of the resulting purple solution was measured at 570 nm on a spectrophotometer .
[0055] ROS analysis
[0056] The production of ROS by the Jurkat cells exposed tothe device was evaluated by means of the NBT (nitroblue tetrazolium) assay, performed as above . The enzymatic activity (production of superoxide anion 02~) is reported as the stimulation index of the NBT reduction (SI ) , calculated as the ratio between the optical density (OD) of the treated and of the control cells . The SI index for the control was considered to be 1.
[0057] Results
[0058] Investigations were carried out, according to the parameters previously described, first of all on the cell lines SH-SY5Y human neuroblastoma cell line and JURKAT -human T lymphocyte cell line using the three LEDs both individually and together .
[0059] From the experiments carried out, cell viability is significantly safeguarded by the application of all three LEDs considered individually, or turned on simultaneously. Only the green LED, used individually, proved ineffective for the Jurkat line . The most relevant action was observed in relation to the reduction of oxidative stress .
[0060] The investigation of oxidative stress was carried out through the quantification of reactive oxygen species (ROS) . The results relating to oxidative stress showed that the stimulating wavelengths were effective, but the best performance was obtained with the three LEDs turned on simultaneously .In consideration of the results obtained, in a subsequent experiment, the three LEDs (Red, green and Blue) were assembled as reported in device 1 and, considering the histology and cell type of the retina, the ARPE-19 - human retinal pigment epithelial cell line was used as cell line .
[0061] The MTT assay for cytotoxicity was carried out, the results of which revealed that the three LEDs turned on simultaneously showed no cytotoxicity and a clear antioxidant effect .
[0062] Finally, we evaluated the effects on the concentration of ROS .
[0063] The results suggest that the inflammatory response due to the induced oxidative stress is also involved and it seemed useful to study any anti-inflammatory effects .
[0064] The preliminary studies were carried out evaluating the activation of the TNF-alpha factor . As it is known, the TNF-alpha factor plays an essential role in activating a bidirectional response between inflammation and oxidative stress .
[0065] The results showed that the optimal effect is obtained in the first 15' of stimulation.
[0066] The inventors of this invention identified the intensity of the blue LED to provide "beneficial" effects . In particular, the data in their possession indicate that for luminances below 200 lux, blue light does not worsencell viability and significantly reduces the induced oxidative stress .
[0067] On the basis of clinical observations, the device according to the invention was useful for the following pathologies : maculopathies in general, glaucoma, paralysis of the facial nerve and of the oculomotor nerves, chorioretinopathies, embolism of the ophthalmic artery and of its branches, optic neurites, dry eye syndrome and other diseases of the visual system and of the extrinsic ocular muscles with inflammatory and / or degenerative etiopathogenesis .
[0068] In addition, the device according to the invention can advantageously be used for the treatment of certain pathologies related to defects of the visual system, such as postural anomalies, and peripheral ailments deriving from dysfunctions of the sensorimotor unit of the visual system) .
Claims
C L A I M S1. Device for the treatment of ophthalmic conditions and of pathologies related to dysfunctions of the visual system, comprising a portable support structure applicable to the head of a user and at least one electromagnetic induction group fixed to said portable support structure; said electromagnetic induction group comprising (i) an RLC circuit powered by an alternating voltage generator and (ii) at least one LED emitting at a wavelength between 1064 nm and 400 nm and a power between 1 and 300 Lux; said device being characterised in that said RLC circuit produces an electromagnetic field with a value between 10 and 100 micro Tesla and having an oscillation frequency between IxlO14and 8xl014Hz and in that said at least one LED emits a beam of light that passes through said electromagnetic field.
2. Device according to claim 1, characterized in that said portable support structure is shaped like glasses .
3. Device according to claim 1 or 2, characterized in that said RLC circuit is fixed to said portable support structure and delimits a space occupied by a transparent dielectric .
4. Device according to claim 3, characterized in that said at least one LED is fixed to said portable support structure in correspondence with a transparent dielectric in a decentralized position with respect to the center of saidtransparent dielectric .
5. Device according to one of the preceding claims, characterized in that said device comprises at least three RGB LEDs .
6. Device according to one of the preceding claims, characterized in that the alternating voltage generator has an amplitude between 10 mV and 12 V.
7. Device according to claim 6, characterized in that the alternating voltage generator is an antenna.
8. Device according to claim 7, characterized in that the antenna is a head in the shape of a segment of a sphere .
9. Device according to one of the preceding claims, characterized in that said LED provides a pulsed light with a frequency less than or equal to 1, 000.00 Hz (as amplitude modulation of the light stimulus) .
